Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program...
Alvotech and Teva Pharmaceuticals have announced approval from the US Food and Drug Administration (FDA) for Selarsdi (ustekinumab-aekn) via subcutaneous injection.
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Centocor`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
Janssen-Cilag`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
As Johnson & Johnson's U.S. exclusivity period on its immunology blockbuster Stelara ticks away, another biosimilar player has lined up for the piece of the drug's sales pie.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached settlement...
J&J profit edges past Street view after deals delay Stelara competition
Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology, dermatology, and rheumatology Authorization paves...